메뉴 건너뛰기




Volumn 15, Issue 1, 2012, Pages 59-70

Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma

Author keywords

Angiogenesis; Foretinib; Growth inhibition; HCC

Indexed keywords

BEVACIZUMAB; BIM PROTEIN; BIOLOGICAL MARKER; CYCLIN B1; FORETINIB; GSK 1363089G; MYC PROTEIN; PROTEIN P27; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SORAFENIB; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; ANILIDE; ANTINEOPLASTIC AGENT; QUINOLINE DERIVATIVE;

EID: 84861535274     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-011-9243-z     Document Type: Article
Times cited : (55)

References (42)
  • 2
  • 5
    • 33747830764 scopus 로고    scopus 로고
    • Hepatocellular carcinoma pathogenesis: From genes to environment
    • Farazi PA, DePinho RA (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6:674-687
    • (2006) Nat Rev Cancer , vol.6 , pp. 674-687
    • Farazi, P.A.1    Depinho, R.A.2
  • 7
    • 14644440555 scopus 로고    scopus 로고
    • Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
    • Hicklin DJ, Ellis LM (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23:1011-1027
    • (2005) J Clin Oncol , vol.23 , pp. 1011-1027
    • Hicklin, D.J.1    Ellis, L.M.2
  • 8
    • 4944234987 scopus 로고    scopus 로고
    • Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma
    • Poon RT, Ho JW, Tong CS, Lau C, Ng IO, Fan ST (2004) Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma. Br J Surg 91:1354-1360
    • (2004) Br J Surg , vol.91 , pp. 1354-1360
    • Poon, R.T.1    Ho, J.W.2    Tong, C.S.3    Lau, C.4    Ng, I.O.5    Fan, S.T.6
  • 9
    • 0043163428 scopus 로고    scopus 로고
    • Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery
    • Chao Y, Li CP, Chau GY, Chen CP, King KL, Lui WY, Yen SH, Chang FY, Chan WK, Lee SD (2003) Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery. Ann Surg Oncol 10:355-362
    • (2003) Ann Surg Oncol , vol.10 , pp. 355-362
    • Chao, Y.1    Li, C.P.2    Chau, G.Y.3    Chen, C.P.4    King, K.L.5    Lui, W.Y.6    Yen, S.H.7    Chang, F.Y.8    Chan, W.K.9    Lee, S.D.10
  • 10
    • 33745220780 scopus 로고    scopus 로고
    • Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype
    • Kaposi-Novak P, Lee JS, Gomez-Quiroz L, Coulouarn C, Factor VM, Thorgeirsson SS (2006) Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest 116:1582-1595
    • (2006) J Clin Invest , vol.116 , pp. 1582-1595
    • Kaposi-Novak, P.1    Lee, J.S.2    Gomez-Quiroz, L.3    Coulouarn, C.4    Factor, V.M.5    Thorgeirsson, S.S.6
  • 11
    • 44349155339 scopus 로고    scopus 로고
    • Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma
    • Osada S, Kanematsu M, Imai H, Goshima S (2008) Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma. Hepatogastroenterology 55:544-549
    • (2008) Hepatogastroenterology , vol.55 , pp. 544-549
    • Osada, S.1    Kanematsu, M.2    Imai, H.3    Goshima, S.4
  • 14
    • 0030951358 scopus 로고    scopus 로고
    • Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma
    • Ueki T, Fujimoto J, Suzuki T, Yamamoto H, Okamoto E (1997) Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma. Hepatology 25:619-623
    • (1997) Hepatology , vol.25 , pp. 619-623
    • Ueki, T.1    Fujimoto, J.2    Suzuki, T.3    Yamamoto, H.4    Okamoto, E.5
  • 16
    • 0030857813 scopus 로고    scopus 로고
    • Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met, TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas
    • Kiss A, Wang NJ, Xie JP, Thorgeirsson SS (1997) Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met, TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas. Clin Cancer Res 3:1059-1066
    • (1997) Clin Cancer Res , vol.3 , pp. 1059-1066
    • Kiss, A.1    Wang, N.J.2    Xie, J.P.3    Thorgeirsson, S.S.4
  • 19
    • 74549209715 scopus 로고    scopus 로고
    • Hepatocyte growth factor (HGF) is a prognostic biomarker for overall survival and a pharmacodynamic biomarker for sorafenib response in the SHARP phase III HCC trial
    • Sept 12-16, 2008, Stockholm, Sweden. Abstract #4600
    • Pena C, Shan M, Wilhelm S, Lathia C (2008) Hepatocyte growth factor (HGF) is a prognostic biomarker for overall survival and a pharmacodynamic biomarker for sorafenib response in the SHARP phase III HCC trial. 33rd European society for medical oncology (ESMO) congress, Sept 12-16, 2008, Stockholm, Sweden. Abstract #4600
    • (2008) 33rd European Society for Medical Oncology (ESMO) Congress
    • Pena, C.1    Shan, M.2    Wilhelm, S.3    Lathia, C.4
  • 23
    • 33846812600 scopus 로고    scopus 로고
    • Xenografts of human hepatocellular carcinoma: A useful model for testing drugs
    • Huynh H, Soo KC, Chow PK, Panasci L, Tran E (2006) Xenografts of human hepatocellular carcinoma: a useful model for testing drugs. Clin Cancer Res 12:4306-4314
    • (2006) Clin Cancer Res , vol.12 , pp. 4306-4314
    • Huynh, H.1    Soo, K.C.2    Chow, P.K.3    Panasci, L.4    Tran, E.5
  • 26
    • 0038697632 scopus 로고    scopus 로고
    • How to make tubes: Signaling by the Met receptor tyrosine kinase
    • Rosario M, Birchmeier W (2003) How to make tubes: signaling by the Met receptor tyrosine kinase. Trends Cell Biol 13:328-335
    • (2003) Trends Cell Biol , vol.13 , pp. 328-335
    • Rosario, M.1    Birchmeier, W.2
  • 29
    • 58149175849 scopus 로고    scopus 로고
    • Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma
    • Huynh H, Ngo VC, Fargnoli J, Ayers M, Soo KC, Koong HN, Thng CH, Ong HS, Chung A, Chow P, Pollock P, Byron S, Tran E (2008) Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma. Clin Cancer Res 14:6146-6153
    • (2008) Clin Cancer Res , vol.14 , pp. 6146-6153
    • Huynh, H.1    Ngo, V.C.2    Fargnoli, J.3    Ayers, M.4    Soo, K.C.5    Koong, H.N.6    Thng, C.H.7    Ong, H.S.8    Chung, A.9    Chow, P.10    Pollock, P.11    Byron, S.12    Tran, E.13
  • 32
    • 0027245446 scopus 로고
    • Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: Interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis
    • Murakami H, Sanderson ND, Nagy P, Marino PA, Merlino G, Thorgeirsson SS (1993) Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res 53:1719-1723
    • (1993) Cancer Res , vol.53 , pp. 1719-1723
    • Murakami, H.1    Sanderson, N.D.2    Nagy, P.3    Marino, P.A.4    Merlino, G.5    Thorgeirsson, S.S.6
  • 35
    • 14944350367 scopus 로고    scopus 로고
    • Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor
    • Gallicchio M, Mitola S, Valdembri D, Fantozzi R, Varnum B, Avanzi GC, Bussolino F (2005) Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor. Blood 105(5):1970-1976
    • (2005) Blood , vol.105 , Issue.5 , pp. 1970-1976
    • Gallicchio, M.1    Mitola, S.2    Valdembri, D.3    Fantozzi, R.4    Varnum, B.5    Avanzi, G.C.6    Bussolino, F.7
  • 36
    • 77954238997 scopus 로고    scopus 로고
    • Reduction of tumor invasiveness and metastasis and prolongation of survival of RIP-Tag2 mice after inhibition of VEGFR plus c-Met by XL184
    • Sennino B, Naylor RM, Tabruyn SP, You WK, Aftab DA, McDonald DM (2009) Reduction of tumor invasiveness and metastasis and prolongation of survival of RIP-Tag2 mice after inhibition of VEGFR plus c-Met by XL184. Mol Cancer Ther 8:A13
    • (2009) Mol Cancer Ther , vol.8
    • Sennino, B.1    Naylor, R.M.2    Tabruyn, S.P.3    You, W.K.4    Aftab, D.A.5    McDonald, D.M.6
  • 38
    • 0242331653 scopus 로고    scopus 로고
    • Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation
    • Zhang YW, Su Y, Volpert OV, Vande Woude GF (2003) Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc Natl Acad Sci USA 100:12718-12723
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 12718-12723
    • Zhang, Y.W.1    Su, Y.2    Volpert, O.V.3    Vande Woude, G.F.4
  • 39
    • 60649116477 scopus 로고    scopus 로고
    • Silencing or fueling metastasis with VEGF inhibitors: Antiangiogenesis revisited
    • Loges S, Mazzone M, Hohensinner P, Carmeliet P (2009) Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. Cancer Cell 15:167-170
    • (2009) Cancer Cell , vol.15 , pp. 167-170
    • Loges, S.1    Mazzone, M.2    Hohensinner, P.3    Carmeliet, P.4
  • 42
    • 44449151030 scopus 로고    scopus 로고
    • Drug development of MET inhibitors: Targeting oncogene addiction and expedience
    • Comoglio PM, Giordano S, Trusolino L (2008) Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 7:504-516
    • (2008) Nat Rev Drug Discov , vol.7 , pp. 504-516
    • Comoglio, P.M.1    Giordano, S.2    Trusolino, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.